$A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myeloma$

A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myeloma

Dinner, Shira; Dunn, Tamara J.; Price, Elizabeth; Coutré, Steven E.; Gotlib, Jason; Berube, Caroline; Kaufman, Gregory P.; Medeiros, Bruno C.; Liedtke, Michaela

期刊名称International Journal of Hematology
作者Dinner, Shira; Dunn, Tamara J.; Price, Elizabeth; Coutré, Steven E.; Gotlib, Jason; Berube, Caroline; Kaufman, Gregory P.; Medeiros, Bruno C.; Liedtke, Michaela
印刷ISSN0925-5710
电子ISSN1865-3774
文件大小919.09KB
发表时间2018-5-25
DOI10.1007/s12185-018-2468-5

发现好书期刊，享受阅读乐趣

A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myeloma